Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009-Reference-Cited by-同舟云学术

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009

Published:2012-06 Issue:28 Volume:30 Page:4240-4248
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Chen Wilbur H.,Winokur Patricia L.,Edwards Kathryn M.,Jackson Lisa A.,Wald Anna,Walter Emmanuel B.,Noah Diana L.,Wolff Mark,Kotloff Karen L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.

2. The President's Council of Advisors on Science and Technology Executive Report. U.S. Preparations for the 2009-H1N1 influenza; August 7, 2009.

3. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine;Treanor;New England Journal of Medicine,2006

4. Response to a monovalent 2009 influenza A (H1N1) vaccine;Greenberg;New England Journal of Medicine,2009

5. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials;Plennevaux;Lancet,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults;2022-10-04

2. Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial;Vaccine;2022-05

3. Racial and Ethnic Diversity in SARS-CoV-2 Vaccine Clinical Trials Conducted in the United States;Vaccines;2022-02-14

4. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic;Clinical Therapeutics;2021-06

5. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?;Clinical Therapeutics;2021-03